Market Research Logo

Progenics Pharmaceuticals Inc (PGNX) - Financial and Strategic SWOT Analysis Review

Progenics Pharmaceuticals Inc (PGNX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Progenics Pharmaceuticals Inc (Progenics) is a late-stage biopharmaceutical company that focuses on developing medicines and products for the treatment of cancer and related conditions. Its only commercial product, Relistor, is used for the treatment of opioid-induced constipation. The company’s pipeline comprises therapeutic agents that are designed to target cancer; PSMA-targeted imaging agents for prostate cancer that enable clinicians and patients to visualize and manage their disease; and a phase III candidate for the treatment of HIV. Progenics also offers bone scan index product EXINI Bone BSI tool and is approved for use in Europe, Japan and the US. The company markets Relistor, through a licensing agreement with Salix Pharmaceuticals outside the US except Japan. Progenics is headquartered in New York, the US.

Progenics Pharmaceuticals Inc Key Recent Developments

May 31,2018: Progenics’ Artificial Intelligence Technology for Automated Analysis of PSMA Targeted Prostate Cancer Images to be Featured at the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
May 22,2018: Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform
May 09,2018: Progenics Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
Mar 08,2018: Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update
Nov 02,2017: Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Progenics Pharmaceuticals Inc - Key Facts
Progenics Pharmaceuticals Inc - Key Employees
Progenics Pharmaceuticals Inc - Key Employee Biographies
Progenics Pharmaceuticals Inc - Major Products and Services
Progenics Pharmaceuticals Inc - History
Progenics Pharmaceuticals Inc - Company Statement
Progenics Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Progenics Pharmaceuticals Inc - Business Description
R&D Overview
Progenics Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Progenics Pharmaceuticals Inc - Strengths
Progenics Pharmaceuticals Inc - Weaknesses
Progenics Pharmaceuticals Inc - Opportunities
Progenics Pharmaceuticals Inc - Threats
Progenics Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Progenics Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 31, 2018: Progenics’ Artificial Intelligence Technology for Automated Analysis of PSMA Targeted Prostate Cancer Images to be Featured at the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
May 22, 2018: Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform
May 09, 2018: Progenics Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
Mar 08, 2018: Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update
Nov 02, 2017: Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update
Aug 09, 2017: Progenics Pharmaceuticals Announces Second Quarter 2017 Financial Results and Business Update
Jun 02, 2017: Progenics Pharmaceuticals Announces the Presentation of Data From Two Automated Bone Scan Index Studies at the 2017 ASCO Annual Meeting
May 04, 2017: Progenics Pharmaceuticals Announces First Quarter 2017 Financial Results and Business Update
Apr 20, 2017: Progenics Pharmaceuticals Announces Presentations at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Mar 09, 2017: Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2016 Financial Results and Business Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Progenics Pharmaceuticals Inc, Key Facts
Progenics Pharmaceuticals Inc, Key Employees
Progenics Pharmaceuticals Inc, Key Employee Biographies
Progenics Pharmaceuticals Inc, Major Products and Services
Progenics Pharmaceuticals Inc, History
Progenics Pharmaceuticals Inc, Subsidiaries
Progenics Pharmaceuticals Inc, Key Competitors
Progenics Pharmaceuticals Inc, Ratios based on current share price
Progenics Pharmaceuticals Inc, Annual Ratios
Progenics Pharmaceuticals Inc, Annual Ratios (Cont...1)
Progenics Pharmaceuticals Inc, Annual Ratios (Cont...2)
Progenics Pharmaceuticals Inc, Interim Ratios
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Progenics Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Progenics Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Progenics Pharmaceuticals Inc, Ratio Charts
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report